Inventor
BRITTON THOMAS C
US40 patents
⚠️ This page may combine multiple inventors who share the name “BRITTON THOMAS C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DOW CHEMICAL CO
13 patentsUS4258138AMar 24, 1981
Method of foaming thermoplastic polymeric materials using tetrazole-containing heterocycles
DOW CHEMICAL CO5 citations63
US4237049ADec 2, 1980
Method for preparing 6-phenyl-triazolo or imidazolo-(2,3,4)-benzotriazepines and the novel intermediates used therewith
DOW CHEMICAL CO4 citations62
US4144233AMar 13, 1979
Method for preparing benzo-(1,3,4)-benzotriazepines
DOW CHEMICAL CO5 citations62
US4094871AJun 13, 1978
1,3,4-Benzotriazepine-2-thiones
DOW CHEMICAL CO3 citations62
US3933833AJan 20, 1976
Phenyl -thiourea, -carbothioamide and -carbonothioamide derivatives
DOW CHEMICAL CO6 citations62
US4286090AAug 25, 1981
Novel tetrazolo [4,5-C][1,2,3]benzotriazines
DOW CHEMICAL CO1 citations52
US4194000AMar 18, 1980
Psychoactive 1,3,4-benzotriazepine-2-thiones and a method for treating central nervous system depression and anxiety
DOW CHEMICAL CO0 citations51
US4189588AFeb 19, 1980
Method for preparing 6-phenyl-triazolo or imidazolo-(1,3,4)-benzotriazepines and the novel intermediates used therewith
DOW CHEMICAL CO0 citations51
US4168310ASep 18, 1979
Psychoactive 1,3,4-benzotriazepine-2-thiones and a method for treating central nervous system depression and anxiety
DOW CHEMICAL CO0 citations51
US4163104AJul 31, 1979
Heterocyclic containing hydrazinecarbothioamides
DOW CHEMICAL CO1 citations51
US4151166AApr 24, 1979
Tricyclic compounds
DOW CHEMICAL CO0 citations51
US4127572ANov 28, 1978
Method of using 2(1H)-quinazolinethiones
DOW CHEMICAL CO1 citations51
US4093805AJun 6, 1978
4-Hydroxy-3,4-dihydro-2(1H)-quinazolinethiones
DOW CHEMICAL CO0 citations51
ATHENA NEUROSCIENCES INC
10 patentsUS6653303B1Nov 25, 2003
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC16 citations92
US6544978B2Apr 8, 2003
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC16 citations92
US6541466B2Apr 1, 2003
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC10 citations82
US6635632B1Oct 21, 2003
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC6 citations73
US6667305B1Dec 23, 2003
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC1 citations62
US6632811B2Oct 14, 2003
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC1 citations62
US6559141B2May 6, 2003
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC2 citations62
US6579867B2Jun 17, 2003
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC2 citations61
US7390801B2Jun 24, 2008
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC0 citations52
US6683075B1Jan 27, 2004
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
ATHENA NEUROSCIENCES INC2 citations52
LILLY CO ELI
9 patentsUS5420266AMay 30, 1995
Process for anomerizing nucleosides
LILLY CO ELI59 citations93
US5618951AApr 8, 1997
Process for preparing 2,2-difluoroketene silyl acetals and α, α-βsilyloxy-1,3-dioxolane-4-propanoic acid esters
LILLY CO ELI36 citations92
US6245761B1Jun 12, 2001
Indolyl neuropeptide Y receptor antagonists
LILLY CO ELI21 citations83
US6888022B2May 3, 2005
Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis
LILLY CO ELI4 citations62
US5574169ANov 12, 1996
Substituted pyrazolidin-3-one derivatives
LILLY CO ELI2 citations61
US5399708AMar 21, 1995
Pyrazolidin-3-one derivatives
LILLY CO ELI2 citations61
US5356935AOct 18, 1994
Reduced phenanthrenes
LILLY CO ELI4 citations57
US6951854B1Oct 4, 2005
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
LILLY CO ELI0 citations52
US6906056B2Jun 14, 2005
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
LILLY CO ELI0 citations50
ELAN PHARM INC
7 patentsUS6509331B1Jan 21, 2003
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ELAN PHARM INC81 citations97
US6191166B1Feb 20, 2001
Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis
ELAN PHARM INC83 citations97
US6211235B1Apr 3, 2001
Compounds for inhibiting β-amyloid peptide release and/or its synthesis
ELAN PHARM INC46 citations92
US6207710B1Mar 27, 2001
Compounds for inhibiting β-amyloid peptide release and/or its synthesis
ELAN PHARM INC22 citations84
US6476263B1Nov 5, 2002
Compounds for inhibiting β-amyloid peptide release and/or its synthesis
ELAN PHARM INC5 citations63
US6861558B2Mar 1, 2005
Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis
ELAN PHARM INC2 citations62
US6774125B2Aug 10, 2004
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ELAN PHARM INC0 citations41